Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 30 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nurix Therapeutics, Inc. | 3,394,333 | reported | 28 Jul 2020 | tx 12+6,672,548−6,672,548 |
| NGM BIOPHARMACEUTICALS INC | 949,862 | reported | 16 Nov 2023 | tx 57+2,823,468 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Nov 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 16,791 | 0.71 USD | |
| 16 Nov 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 5,840 | 0.62 USD | |
| 23 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 9,900 | 5.00 USD | |
| 10 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 100,070 | 4.84 USD | |
| 11 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 209,000 | 4.76 USD | |
| 11 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 209,000 | 4.76 USD | |
| 10 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 100,070 | 4.84 USD | |
| 03 Nov 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 104,090 | 4.99 USD | |
| 04 Nov 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 35,058 | 4.72 USD | |
| 27 Oct 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 76,877 | 4.86 USD | |
| 19 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 682 | 13.25 USD | |
| 20 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 18,406 | 13.48 USD | |
| 20 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 628 | 13.48 USD | |
| 19 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 19,984 | 13.25 USD | |
| 12 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 2,728 | 11.62 USD | |
| 12 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 79,945 | 11.62 USD | |
| 11 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 88 | 11.85 USD | |
| 11 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 2,564 | 11.85 USD | first after silence |
| 11 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 2,657 | 11.23 USD | |
| 12 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 485 | 11.81 USD | |
| 11 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 77,866 | 11.23 USD | |
| 12 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 17 | 11.81 USD | |
| 12 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 485 | 11.81 USD | |
| 12 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 2,728 | 11.62 USD | |
| 12 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 79,945 | 11.62 USD |
1 purchase reported after at least 12 months of silence — most recent on 11 May 2022.